CFTR and asthma: The goal is, by considering the phenotype and genotype of the CFTR gene, to achieve better stratification in asthma classifications and so improve disease prognosis for hypersecreting patients and, ultimately, enhance the efficiency of current treatments and develop targeted and personalized future treatments.